Meet Fortrea’s Market Access Consulting & HEOR team at ISPOR Europe 2025!
We look forward to meeting you at the International Society for Health Economics and Outcomes Research (ISPOR) meeting in Glasgow, Scotland, UK, from November 9-12.
Our team of Market Access Consulting & HEOR professionals will be on hand to learn about your company’s needs and current activities in market access and HEOR. We’d be happy to discuss integrated evidence plans, external control arms, non-interventional studies, value demonstration, health economic modeling, payer insights and market access strategy. Stop by one of our posters to see examples of our work in market access strategy, health economic modeling and RWE analysis.
We leverage our knowledge and experience to help companies clarify product value, generate robust evidence, demonstrate value to stakeholders, and support pre-launch and post-launch activities. Partner with us to ensure your product is on track to meet decision maker needs and optimize access.
Discover our capabilities: Market Access Consulting & HEOR
Meet our Team
Posters
10 NOVEMBER | POSTER SESSION 1 | 10:30 - 13:30
- Comparative Health Economic Evaluation of Alzheimer’s Diagnostic Treatment Strategies in the Era of Amyloid-Targeting Therapies: A Conceptual Model Framework [EE140]
- Health Utilities Among Patients with Chronic Rhinosinusitis with Nasal Polyps: An Exploratory Analysis from the WAYPOINT Trial [EE495]
- A Comparative Analysis of Similarities and Differences of RWE Standards Across Regulatory and Health Technology Assessment Bodies [HPR5]
Fortrea presenter: Christianna Pepingco
10 NOVEMBER | POSTER SESSION 2 | 16:00 – 19:00
- Digital Therapeutics in Europe: A Structured Review Of Reimbursement and Access Pathways [MT14]
11 NOVEMBER | POSTER SESSION 4 | 16:00 – 19:00
- Exploring LLMs in the Conceptual and Functional Construction of Health Economic Models: A Case Study on Alzheimer’s Diagnostic Cost-Effectiveness Model [EE457]
Fortrea presenter: Emilija Veljanoska - Trends, Regulatory Landscape and Challenges in the Adoption of Digital Endpoints in Clinical Trials: A Scoping Review [HPR173]
Fortrea presenter: António Cardoso - Healthcare Resource Use Among Patients with Chronic Rhinosinusitis with Nasal Polyps in the United Kingdom: Results of an Expert Elicitation Survey [EE503]
11 NOVEMBER | POSTER SESSION 5 | 09:00 – 11:30
- Technical validation of health economic models – is there a gold standard? Assessment and refinement of current checklist tools [EE684]
- Impact of Anosmia Severity on Health Utility Values in Chronic Rhinosinusitis with Nasal Polyps: An Exploratory Analysis from the WAYPOINT Trial [EE525]